The Flanders region is well recognized for its pioneering role in life sciences, healthcare, and the broad biotechnology field. The AI Research Program will further strengthen the role in Flanders in this field by elaborating the added value of Machine Learning and AI on the big data sets that are being collected and becoming available. In the use cases where expert knowledge can contribute to the algorithms developed, the professional caregivers are involved from the conceptual phase on. Next to this trustworthiness in the broad sense will be built-in into all these cases.
In first instance the AI program results will tested for impact in three major health categories: precision medicine, clinical decision support systems, and hospital decision support systems.
Within the area of precision medicine, two use cases are currently defined; one focusing on technological advances related to novel single-cell technologies, and one related to a specific disease (multiple sclerosis). Likewise, within clinical decision support system both a disease-specific (epilepsy monitoring) as well as a technological use case are defined (medical imaging). Finally, for the case of hospital decision support, predicting how long patients will stay hospitalized and optimizing hospital logistics based on these models will be realized.
|Use case||Contact Person|
|Visualisation of Single Cell Data and Segmentation of 3D Electron Microscopy Images||Yvan Saeys, VIB/UGent|
|Improving MS Treatments||Liesbet Peeters, UHasselt|
|Automated Detection of Epileptic Seizures||Sabine Van Huffel,Maarten De Vos, KU Leuven|
|Segmentation and Classification for Radiation Oncology and Radiology||Matthew Blashko, KULeuven|
|Prediction of Length of Stay in Hospitals||Bart De Moor, KU Leuven|
Multiple research groups collaborate on this research domain. The above table only mentions the contact person and his/her affiliation.